IGF1 and Anxiety: In conclusion, taken together, in the present study of the Ukrainian cohort, higher serum IGF-1 concentrations were associated with MDD status (in the age cohort of 18–54 years old), the severity of hypothymia, anxiety, and cognitive decline (predominantly executive dysfunction).